Outpatient and Home Chemotherapy with Novel Local Control Strategies in Desmoplastic Small Round Cell Tumor
暂无分享,去创建一个
[1] P. Adamson,et al. A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: A Children's Oncology Group study , 2008, Pediatric blood & cancer.
[2] A. Davidoff,et al. Desmoplastic small round cell tumor in childhood: The St. Jude Children's Research Hospital experience , 2007, Pediatric blood & cancer.
[3] R. Jain,et al. Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practice. , 2006, Seminars in oncology.
[4] S. Wilhelm,et al. Discovery and development of sorafenib: a multikinase inhibitor for treating cancer , 2006, Nature Reviews Drug Discovery.
[5] P. Anderson,et al. Novel therapeutic approaches in pediatric and young adult sarcomas , 2006, Current oncology reports.
[6] M. Carli,et al. Phase II study of a protracted irinotecan schedule in children with refractory or recurrent soft tissue sarcoma , 2006, Cancer.
[7] J. Khoury,et al. Osteosarcoma Among Children Aged 5 Years or Younger: The St. Jude Children's Research Hospital Experience , 2006, Journal of pediatric hematology/oncology.
[8] P. Sugarbaker. A curative approach to peritoneal carcinomatosis from colorectal cancer. , 2005, Seminars in oncology.
[9] Y. Iwamoto,et al. Antitumor effects of histone deacetylase inhibitor on Ewing's family tumors , 2005, International journal of cancer.
[10] P. Sugarbaker,et al. Strategies for management of the peritoneal surface component of cancer: cytoreductive surgery plus perioperative intraperitoneal chemotherapy , 2005, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
[11] E. Brun,et al. Clinical Perspective on Desmoplastic Small Round-Cell Tumor , 2004, Oncology.
[12] A. Ferrari,et al. Vinorelbine and low‐dose cyclophosphamide in the treatment of pediatric sarcomas , 2004, Cancer.
[13] F. Kwiatkowski,et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Michael Gnant,et al. Heat shock protein expression induced by percutaneous radiofrequency ablation of hepatocellular carcinoma in vivo. , 2004, International journal of oncology.
[15] P. Houghton,et al. Phase I Trial of Temozolomide and Protracted Irinotecan in Pediatric Patients with Refractory Solid Tumors , 2004, Clinical Cancer Research.
[16] M. Miranda,et al. Use of radiofrequency for ablation of unresectable hepatic metastasis in desmoplastic small round cell tumor. , 2003, Medical and pediatric oncology.
[17] P. Sugarbaker,et al. A review of peritoneal mesothelioma at the Washington Cancer Institute. , 2003, Surgical oncology clinics of North America.
[18] P. Sugarbaker,et al. New Perspectives in the Management of Colorectal Cancer: What about Peritoneal Carcinomatosis? , 2003, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.
[19] F. Gilly,et al. Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] P. Rosoff,et al. Successful clinical response to irinotecan in desmoplastic round blue cell tumor. , 1999, Medical and pediatric oncology.
[21] C. Manivel,et al. Intra-abdominal desmoplastic small round cell tumor: immunohistochemical evidence for up-regulation of autocrine and paracrine growth factors. , 1998, Annals of clinical and laboratory science.
[22] W. Gerald,et al. Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] W. Gerald,et al. Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] K. Jablonski,et al. Prognostic Features of 51 Colorectal and 130 Appendiceal Cancer Patients with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy , 1995, Annals of surgery.
[25] W. Gerald,et al. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. , 1994, Cancer research.
[26] J. Donohue,et al. Pseudomyxoma Peritonei Long‐Term Patient Survival with an Aggressive Regional Approach , 1994, Annals of surgery.
[27] K. Skubitz,et al. Ambulatory continuous infusion ifosfamide with oral etoposide in advanced sarcomas , 1993, Cancer.
[28] S. Wolden,et al. Results of multimodal treatment for desmoplastic small round cell tumors. , 2005, Journal of pediatric surgery.
[29] P. H. Sugarbaker,et al. Pseudomyxoma peritonei syndrome. , 1996, Advances in surgery.
[30] W. Gerald,et al. Case 2. Desmoplastic small cell tumor with divergent differentiation. , 1989, Pediatric pathology.